The 'dt2' app aims to improve diabetes management and prevention in the UK by providing a comprehensive platform for users to monitor their health and connect with others. It addresses the shortcomings of existing diabetes apps by offering features like behavioral and metabolic risk tracking, social rewards, and an engaging user interface. The project involves pilot studies at Imperial College London and Chelsea and Westminster Hospital, with financial support from partners like IBM and Novartis.